Literature DB >> 26163472

Acute Cardio-Renal Syndrome as a Cause for Renal Deterioration Among Myocardial Infarction Patients Treated With Primary Percutaneous Intervention.

Yacov Shacham1, Eran Leshem-Rubinow2, Amir Gal-Oz3, Yaron Arbel2, Gad Keren2, Arie Roth2, Arie Steinvil2.   

Abstract

BACKGROUND: Early hemodynamic impairment frequently complicates myocardial injury, however, limited data are present regarding its direct association with acute kidney injury (AKI) after ST segment elevation myocardial infarction (STEMI) in patients who undergo primary percutaneous coronary intervention (PCI). We evaluated the effect of acute hemodynamic derangement on the risk of AKI among STEMI patients who undergo primary PCI.
METHODS: We performed a retrospective analysis of 1656 consecutive patients admitted with the diagnosis of STEMI between January 2008 and December 2014, and treated with primary PCI. Medical records were reviewed for the presence of various clinical parameters of hemodynamic derangement and for the occurrence of AKI.
RESULTS: Mean age was 61 ± 13 and 1329 (80%) were men. AKI occurred in 168 patients (10%). Patients with AKI were older, of female sex, with more comorbidities, had longer time to reperfusion, and were more likely to have hemodynamic impairment including critical state, congestive heart failure, life-threatening arrhythmias, and worse left ventricular function (P < 0.001 for all). In a multivariate logistic regression model critical state (odds ratio [OR], 3.33; 95% confidence interval [CI], 1.39-7.8; P = 0.006), reduced left ventricular ejection fraction (OR, 0.95; 95% CI, 0.92-0.99; P = 0.03), congestive heart failure (OR, 2.34; 95% CI, 1.02-5.39; P = 0.04), and a trend for time to coronary reperfusion (OR, 1.01; 95% CI, 1.00-1.01; P = 0.07) emerged as independent predictors of AKI.
CONCLUSIONS: Among STEMI patients who underwent primary PCI AKI should not be assumed to be solely contrast-induced nephropathy and acute hemodynamic abnormalities should be considered.
Copyright © 2015 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26163472     DOI: 10.1016/j.cjca.2015.03.031

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  21 in total

1.  Prognostic Implications of Chronic Kidney Disease on Patients Presenting with ST-Segment Elevation Myocardial Infarction with versus without Stent Thrombosis.

Authors:  Gilad Margolis; Shahar Vig; Nir Flint; Shafik Khoury; Michael Barkagan; Gad Keren; Yacov Shacham
Journal:  Cardiorenal Med       Date:  2017-01-28       Impact factor: 2.041

2.  Acute kidney injury based on the KDIGO criteria among ST elevation myocardial infarction patients treated by primary percutaneous intervention.

Authors:  Gilad Margolis; Amir Gal-Oz; Sevan Letourneau-Shesaf; Shafik Khoury; Gad Keren; Yacov Shacham
Journal:  J Nephrol       Date:  2017-11-28       Impact factor: 3.902

3.  Serum Uric Acid Levels and Renal Impairment among ST-Segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Intervention.

Authors:  Yacov Shacham; Amir Gal-Oz; Nir Flint; Gad Keren; Yaron Arbel
Journal:  Cardiorenal Med       Date:  2016-02-25       Impact factor: 2.041

4.  Combined impact of chronic kidney disease and contrast-induced nephropathy on long-term outcomes in patients with ST-segment elevation acute myocardial infarction who undergo primary percutaneous coronary intervention.

Authors:  Hidefumi Nakahashi; Masami Kosuge; Kentaro Sakamaki; Masayoshi Kiyokuni; Toshiaki Ebina; Kiyoshi Hibi; Kengo Tsukahara; Noriaki Iwahashi; Shotaro Kuji; Mari S Oba; Satoshi Umemura; Kazuo Kimura
Journal:  Heart Vessels       Date:  2016-04-22       Impact factor: 2.037

5.  Does N-terminal pro-brain natriuretic peptide add prognostic value to the Mehran risk score for contrast-induced nephropathy and long-term outcomes after primary percutaneous coronary intervention?

Authors:  Yuan-Hui Liu; Lei Jiang; Ji-Yan Chen; Ning Tan; Yong Liu; Peng Cheng He
Journal:  Int Urol Nephrol       Date:  2016-07-29       Impact factor: 2.370

6.  Prognostic Implications of Acute Renal Impairment among ST Elevation Myocardial Infarction Patients with Preserved Left Ventricular Function.

Authors:  Yacov Shacham; Amir Gal-Oz; Jeremy Ben-Shoshan; Gad Keren; Yaron Arbel
Journal:  Cardiorenal Med       Date:  2016-02-03       Impact factor: 2.041

7.  Development of a novel score to predict the risk of acute kidney injury in patient with acute myocardial infarction.

Authors:  Khalid Abusaada; Cai Yuan; Rafay Sabzwari; Khurram Butt; Aadil Maqsood
Journal:  J Nephrol       Date:  2016-06-14       Impact factor: 3.902

Review 8.  Acute kidney injury among ST elevation myocardial infarction patients treated by primary percutaneous coronary intervention: a multifactorial entity.

Authors:  Yacov Shacham; Arie Steinvil; Yaron Arbel
Journal:  J Nephrol       Date:  2016-02-10       Impact factor: 3.902

9.  Echocardiographic correlates of left ventricular filling pressures and acute cardio-renal syndrome in ST segment elevation myocardial infarction patients.

Authors:  Nir Flint; Natalia Kaufman; Amir Gal-Oz; Gilad Margolis; Yan Topilsky; Gad Keren; Yacov Shacham
Journal:  Clin Res Cardiol       Date:  2016-08-22       Impact factor: 5.460

10.  Prognostic significance of renal dysfunction and its change pattern on outcomes in patients with acute coronary syndrome treated with emergent percutaneous coronary intervention.

Authors:  Kenichiro Otsuka; Kenei Shimada; Hisashi Katayama; Haruo Nakamura; Hirotoshi Ishikawa; Hisateru Takeda; Kohei Fujimoto; Noriaki Kasayuki; Minoru Yoshiyama
Journal:  Heart Vessels       Date:  2018-11-01       Impact factor: 2.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.